BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31753390)

  • 1. Silicon-calcium phosphate ceramics and silicon-calcium phosphate cements: Substrates to customize the release of antibiotics according to the idiosyncrasies of the patient.
    Lucas-Aparicio J; Manchón Á; Rueda C; Pintado C; Torres J; Alkhraisat MH; López-Cabarcos E
    Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110173. PubMed ID: 31753390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Si substitution on the reactivity of α-tricalcium phosphate.
    Motisuke M; Mestres G; Renó CO; Carrodeguas RG; Zavaglia CAC; Ginebra MP
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():816-821. PubMed ID: 28415534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silicon substitution in the calcium phosphate bioceramics.
    Pietak AM; Reid JW; Stott MJ; Sayer M
    Biomaterials; 2007 Oct; 28(28):4023-32. PubMed ID: 17544500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silicon-stabilized α-tricalcium phosphate and its use in a calcium phosphate cement: characterization and cell response.
    Mestres G; Le Van C; Ginebra MP
    Acta Biomater; 2012 Mar; 8(3):1169-79. PubMed ID: 22154863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase formation and evolution in the silicon substituted tricalcium phosphate/apatite system.
    Reid JW; Pietak A; Sayer M; Dunfield D; Smith TJ
    Biomaterials; 2005 Jun; 26(16):2887-97. PubMed ID: 15603784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation and silicon excretion of the calcium silicate bioactive ceramics during bone regeneration using rabbit femur defect model.
    Lin K; Liu Y; Huang H; Chen L; Wang Z; Chang J
    J Mater Sci Mater Med; 2015 Jun; 26(6):197. PubMed ID: 26099345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review paper: behavior of ceramic biomaterials derived from tricalcium phosphate in physiological condition.
    Kamitakahara M; Ohtsuki C; Miyazaki T
    J Biomater Appl; 2008 Nov; 23(3):197-212. PubMed ID: 18996965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron spin resonance in silicon substituted apatite and tricalcium phosphate.
    Pietak AM; Reid JW; Sayer M
    Biomaterials; 2005 Jun; 26(18):3819-30. PubMed ID: 15626430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Mg and Si co-substitution on microstructure and strength of tricalcium phosphate ceramics.
    García-Páez IH; Carrodeguas RG; De Aza AH; Baudín C; Pena P
    J Mech Behav Biomed Mater; 2014 Feb; 30():1-15. PubMed ID: 24216308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of calcium phosphate ceramics for drug delivery applications in bone diseases: A review of the parameters affecting the loading and release of the therapeutic substance.
    Parent M; Baradari H; Champion E; Damia C; Viana-Trecant M
    J Control Release; 2017 Apr; 252():1-17. PubMed ID: 28232225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and composition of silicon-stabilized tricalcium phosphate.
    Sayer M; Stratilatov AD; Reid J; Calderin L; Stott MJ; Yin X; MacKenzie M; Smith TJ; Hendry JA; Langstaff SD
    Biomaterials; 2003 Feb; 24(3):369-82. PubMed ID: 12423592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal and Bioresorbable Calcium Phosphate Cements Fabricated by Silver-Containing Tricalcium Phosphate Microspheres.
    Honda M; Kawanobe Y; Nagata K; Ishii K; Matsumoto M; Aizawa M
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Composite material consisting of microporous β-TCP ceramic and alginate for delayed release of antibiotics.
    Seidenstuecker M; Ruehe J; Suedkamp NP; Serr A; Wittmer A; Bohner M; Bernstein A; Mayr HO
    Acta Biomater; 2017 Mar; 51():433-446. PubMed ID: 28104468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of microstructure for the early antibiotic release of fresh and pre-set calcium phosphate cements.
    Canal C; Pastorino D; Mestres G; Schuler P; Ginebra MP
    Acta Biomater; 2013 Sep; 9(9):8403-12. PubMed ID: 23707499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of silicate incorporation on in vivo responses of α-tricalcium phosphate ceramics.
    Kamitakahara M; Tatsukawa E; Shibata Y; Umemoto S; Yokoi T; Ioku K; Ikeda T
    J Mater Sci Mater Med; 2016 May; 27(5):97. PubMed ID: 27003839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating the antibiotic drug release from β-tricalcium phosphate ceramics by atmospheric plasma surface engineering.
    Canal C; Modic M; Cvelbar U; Ginebra MP
    Biomater Sci; 2016 Oct; 4(10):1454-61. PubMed ID: 27528375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced bioceramic composite for bone tissue engineering: design principles and structure-bioactivity relationship.
    El-Ghannam AR
    J Biomed Mater Res A; 2004 Jun; 69(3):490-501. PubMed ID: 15127396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of calcium phosphate ceramic composition and structure on in vitro behavior. II. Precipitation.
    Radin SR; Ducheyne P
    J Biomed Mater Res; 1993 Jan; 27(1):35-45. PubMed ID: 8380597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silicon-substituted calcium phosphates - a critical view.
    Bohner M
    Biomaterials; 2009 Nov; 30(32):6403-6. PubMed ID: 19695699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of apatite ceramics containing alpha-tricalcium phosphate by immersion in simulated body fluid.
    Hirakata LM; Kon M; Asaoka K
    Biomed Mater Eng; 2003; 13(3):247-59. PubMed ID: 12883174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.